Gemini Therapeutics, Inc. /DE - FORM S-1/A - EX-23.1 - CONSENT OF WITHUMSMITH+BROWN, PC. - August 7, 2020

Attached files

file filename
EX-10.7 - SECURITIES SUBSCRIPTION AGREEMENT BETWEEN THE REGISTRANT AND FS DEVELOPMENT HOLD - Gemini Therapeutics, Inc. /DEfs12020a1ex10-7_fsdevelopmnt.htm
S-1/A - Gemini Therapeutics, Inc. /DEfs12020a1_fsdevelopment.htm
EX-99.3 - FORM OF NOMINATING & CORPORATE GOVERNANCE COMMITTEE CHARTER - Gemini Therapeutics, Inc. /DEfs12020a1ex99-3_fsdevelopmnt.htm
EX-99.2 - FORM OF COMPENSATION COMMITTEE CHARTER - Gemini Therapeutics, Inc. /DEfs12020a1ex99-2_fsdevelopmnt.htm
EX-99.1 - FORM OF AUDIT COMMITTEE CHARTER - Gemini Therapeutics, Inc. /DEfs12020a1ex99-1_fsdevelopmnt.htm
EX-14 - FORM OF CODE OF ETHICS - Gemini Therapeutics, Inc. /DEfs12020a1ex14_fsdevelopmnt.htm
EX-10.8 - FORM OF ADMINISTRATIVE SERVICES AGREEMENT BETWEEN THE REGISTRANT AND FS DEVELOPM - Gemini Therapeutics, Inc. /DEfs12020a1ex10-8_fsdevelopmnt.htm
EX-10.6 - PROMISSORY NOTE ISSUED TO FS DEVELOPMENT HOLDINGS, LLC - Gemini Therapeutics, Inc. /DEfs12020a1ex10-6_fsdevelopmnt.htm
EX-10.5 - FORM OF INDEMNITY AGREEMENT - Gemini Therapeutics, Inc. /DEfs12020a1ex10-5_fsdevelopmnt.htm
EX-10.4 - FORM OF PRIVATE PLACEMENT CLASS A COMMON STOCK PURCHASE AGREEMENT BETWEEN THE RE - Gemini Therapeutics, Inc. /DEfs12020a1ex10-4_fsdevelopmnt.htm
EX-10.3 - FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT, FS DEVELOPMENT HOLDI - Gemini Therapeutics, Inc. /DEfs12020a1ex10-3_fsdevelopmnt.htm
EX-10.2 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - Gemini Therapeutics, Inc. /DEfs12020a1ex10-2_fsdevelopmnt.htm
EX-10.1 - FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, FS DEVELOPMENT HOLDINGS, LLC AND - Gemini Therapeutics, Inc. /DEfs12020a1ex10-1_fsdevelopmnt.htm
EX-5.1 - OPINION OF WHITE & CASE LLP. - Gemini Therapeutics, Inc. /DEfs12020a1ex5-1_fsdevelopmnt.htm
EX-4.1 - SPECIMEN CLASS A COMMON STOCK CERTIFICATE - Gemini Therapeutics, Inc. /DEfs12020a1ex4-1_fsdevelopmnt.htm
EX-3.4 - BYLAWS - Gemini Therapeutics, Inc. /DEfs12020a1ex3-4_fsdevelopmnt.htm
EX-3.3 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Gemini Therapeutics, Inc. /DEfs12020a1ex3-3_fsdevelopmnt.htm
EX-3.2 - CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION - Gemini Therapeutics, Inc. /DEfs12020a1ex3-2_fsdevelopmnt.htm
EX-3.1 - CERTIFICATE OF INCORPORATION - Gemini Therapeutics, Inc. /DEfs12020a1ex3-1_fsdevelopmnt.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Gemini Therapeutics, Inc. /DEfs12020a1ex1-1_fsdevelopmnt.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Amendment No. 1 to Form S-1, of our report dated July 24, 2020, relating to the balance sheet of FS Development Corp. as of June 30, 2020, and the related statements of operations, changes in stockholder’s equity and cash flows for the period from June 25, 2020 (inception) through June 30, 2020, and to the reference to our Firm under the caption “Experts” in the Prospectus.

 

/s/ WithumSmith+Brown, PC  
   
New York, New York  
August 7, 2020  

 

 

Gemini Therapeutics, Inc. /DE Reports